181 related articles for article (PubMed ID: 23895325)
1. Enhancing the utility of adeno-associated virus gene transfer through inducible tissue-specific expression.
Chen SJ; Johnston J; Sandhu A; Bish LT; Hovhannisyan R; Jno-Charles O; Sweeney HL; Wilson JM
Hum Gene Ther Methods; 2013 Aug; 24(4):270-8. PubMed ID: 23895325
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
3. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction.
Flotte TR; Barraza-Ortiz X; Solow R; Afione SA; Carter BJ; Guggino WB
Gene Ther; 1995 Jan; 2(1):29-37. PubMed ID: 7712331
[TBL] [Abstract][Full Text] [Related]
4. Enhancing transduction of the liver by adeno-associated viral vectors.
Nathwani AC; Cochrane M; McIntosh J; Ng CY; Zhou J; Gray JT; Davidoff AM
Gene Ther; 2009 Jan; 16(1):60-9. PubMed ID: 18701909
[TBL] [Abstract][Full Text] [Related]
5. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector.
Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT
Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449
[TBL] [Abstract][Full Text] [Related]
6. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
[TBL] [Abstract][Full Text] [Related]
7. Targeting adipose tissue via systemic gene therapy.
O'Neill SM; Hinkle C; Chen SJ; Sandhu A; Hovhannisyan R; Stephan S; Lagor WR; Ahima RS; Johnston JC; Reilly MP
Gene Ther; 2014 Jul; 21(7):653-61. PubMed ID: 24830434
[TBL] [Abstract][Full Text] [Related]
8. Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors.
Hösel M; Huber A; Bohlen S; Lucifora J; Ronzitti G; Puzzo F; Boisgerault F; Hacker UT; Kwanten WJ; Klöting N; Blüher M; Gluschko A; Schramm M; Utermöhlen O; Bloch W; Mingozzi F; Krut O; Büning H
Hepatology; 2017 Jul; 66(1):252-265. PubMed ID: 28318036
[TBL] [Abstract][Full Text] [Related]
9. Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis.
Apparailly F; Millet V; Noël D; Jacquet C; Sany J; Jorgensen C
Hum Gene Ther; 2002 Jul; 13(10):1179-88. PubMed ID: 12133271
[TBL] [Abstract][Full Text] [Related]
10. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
11. Development of a liver-specific Tet-on inducible system for AAV vectors and its application in the treatment of liver cancer.
Vanrell L; Di Scala M; Blanco L; Otano I; Gil-Farina I; Baldim V; Paneda A; Berraondo P; Beattie SG; Chtarto A; Tenenbaum L; Prieto J; Gonzalez-Aseguinolaza G
Mol Ther; 2011 Jul; 19(7):1245-53. PubMed ID: 21364542
[TBL] [Abstract][Full Text] [Related]
12. AAV-mediated liver-directed gene therapy.
Sands MS
Methods Mol Biol; 2011; 807():141-57. PubMed ID: 22034029
[TBL] [Abstract][Full Text] [Related]
13. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer.
Luebke AE; Foster PK; Muller CD; Peel AL
Hum Gene Ther; 2001 May; 12(7):773-81. PubMed ID: 11339894
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin-regulated control of antiangiogenic tumor therapy following rAAV-mediated gene transfer.
Nguyen M; Huan-Tu G; Gonzalez-Edick M; Rivera VM; Clackson T; Jooss KU; Harding TC
Mol Ther; 2007 May; 15(5):912-20. PubMed ID: 17245354
[TBL] [Abstract][Full Text] [Related]
15. Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar Syndrome Type I.
Bočkor L; Bortolussi G; Iaconcig A; Chiaruttini G; Tiribelli C; Giacca M; Benvenuti F; Zentilin L; Muro AF
Gene Ther; 2017 Oct; 24(10):649-660. PubMed ID: 28805798
[TBL] [Abstract][Full Text] [Related]
16. Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver.
Ohashi K; Nakai H; Couto LB; Kay MA
Hum Gene Ther; 2005 Mar; 16(3):299-306. PubMed ID: 15812225
[TBL] [Abstract][Full Text] [Related]
17. Development of a liver-specific Tet-off AAV8 vector for improved safety of insulin gene therapy for diabetes.
Gan SU; Fu Z; Sia KC; Kon OL; Calne R; Lee KO
J Gene Med; 2019 Jan; 21(1):e3067. PubMed ID: 30592790
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector.
Liu YL; Mingozzi F; Rodriguéz-Colôn SM; Joseph S; Dobrzynski E; Suzuki T; High KA; Herzog RW
Hum Gene Ther; 2004 Aug; 15(8):783-92. PubMed ID: 15319035
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Potency Assay for Adeno-Associated Virus-Based Gene Therapy Vectors Using AAVrh.10 as an Example.
De BP; Chen A; Salami CO; Van de Graaf B; Rosenberg JB; Pagovich OE; Sondhi D; Crystal RG; Kaminsky SM
Hum Gene Ther Methods; 2018 Jun; 29(3):146-155. PubMed ID: 29706115
[TBL] [Abstract][Full Text] [Related]
20. Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression.
Earley LF; Conatser LM; Lue VM; Dobbins AL; Li C; Hirsch ML; Samulski RJ
Hum Gene Ther; 2020 Feb; 31(3-4):151-162. PubMed ID: 31914802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
